- Home
- FATE vs CGO Comparison
FATE vs CGO Comparison
Compare FATE & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- CGO
- Stock Information
- Founded
- FATE 2007
- CGO 2004
- Country
- FATE United States
- CGO United States
- Employees
- FATE N/A
- CGO N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- CGO Investment Managers
- Sector
- FATE Health Care
- CGO Finance
- Exchange
- FATE Nasdaq
- CGO Nasdaq
- Market Cap
- FATE 116.5M
- CGO 116.0M
- IPO Year
- FATE 2013
- CGO N/A
- Fundamental
- Price
- FATE $1.06
- CGO $11.78
- Analyst Decision
- FATE Buy
- CGO
- Analyst Count
- FATE 7
- CGO 0
- Target Price
- FATE $3.92
- CGO N/A
- AVG Volume (30 Days)
- FATE 2.1M
- CGO 34.7K
- Earning Date
- FATE 11-12-2025
- CGO 01-01-0001
- Dividend Yield
- FATE N/A
- CGO 9.25%
- EPS Growth
- FATE N/A
- CGO N/A
- EPS
- FATE N/A
- CGO N/A
- Revenue
- FATE $8,470,000.00
- CGO N/A
- Revenue This Year
- FATE N/A
- CGO N/A
- Revenue Next Year
- FATE N/A
- CGO N/A
- P/E Ratio
- FATE N/A
- CGO N/A
- Revenue Growth
- FATE N/A
- CGO N/A
- 52 Week Low
- FATE $0.66
- CGO $7.90
- 52 Week High
- FATE $3.50
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- FATE 37.34
- CGO 45.97
- Support Level
- FATE $1.00
- CGO $11.48
- Resistance Level
- FATE $1.51
- CGO $12.15
- Average True Range (ATR)
- FATE 0.15
- CGO 0.17
- MACD
- FATE -0.05
- CGO -0.01
- Stochastic Oscillator
- FATE 6.38
- CGO 49.40
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.